Blockchain Registration Transaction Record

Clene (NASDAQ: CLNN) Closes Offering and Placements, Raises $7.3M

Clene (NASDAQ: CLNN) has successfully closed a $7.3 million offering and placements, raising capital to support its development of therapies for neurodegenerative diseases. The financing will enable ongoing discussions with the FDA and ensure the continuation of drug provision to people with ALS under compassionate use programs. The potential NDA filing under the accelerated approval pathway also signals progress in the development of treatments for neurodegenerative diseases.

This news matters as it highlights the successful financial transactions of Clene, a company dedicated to developing therapies for neurodegenerative diseases. The raised capital will support Clene's ongoing discussions with the FDA and ensure the continuation of drug provision to people with ALS under compassionate use programs. The potential NDA filing under the accelerated approval pathway also signals progress in the development of treatments for neurodegenerative diseases.